VLP bivalent norovirus vaccine (Takeda Vaccines)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVLP bivalent norovirus vaccine (Takeda Vaccines)
Drug Alias NameVLP bivalent norovirus vaccine (LigoCyte)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNorwalk virus infectionsNorovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Vaccines Inc
Active IndicationsN/A
Inactive IndicationsNorwalk virus infectionsNorovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A